Important for Clinical Practice

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 22 | ESPEYB25

Yearbook of Paediatric Endocrinology 2025

4. Growth and Growth Factors

Previous section
GH/IGF1 Metabolic Action

Table of contents

Next section
New Potential Indications for Growth Hormone Therapy

ey0022.4-5 | Important for Clinical Practice

4.5. Clinical predictors of good/poor response to growth hormone treatment in children with idiopathic short stature

ey0022.4-6 | Important for Clinical Practice

4.6. Long-acting growth hormone therapy in pediatric growth hormone deficiency: a consensus statement

ey0022.4-7 | Important for Clinical Practice

4.7. Health-related quality of life and problem behavior after GH cessation in adults born small for gestational age: a 12-year follow-up study

ey0022.4-8 | Important for Clinical Practice

4.8. Somapacitan in children born SGA: 52-week efficacy, safety, and IGF-I response results from the phase 2 REAL5 study

ey0022.4-9 | Important for Clinical Practice

4.9. Patterns of brain structure-function coupling variations related to height and growth hormone in children with short stature

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology